The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...
HotCopper.com on MSN19h
Neurizon's fast-track application for flagship drug in Europe received 'positively'While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback